Status:
TERMINATED
Age Influence on Cortical Bone Measured by Ultrasound
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cortical Bone Erosion
Eligibility:
All Genders
18+ years
Brief Summary
The study of this study is to evaluate the age influence on cortical bone strength properties by two methods:HR-pQCT (HighResolution-peripheral quantitativeComputedTomography) and ultrasound. The main...
Detailed Description
The study of this study is to evaluate the age influence on cortical bone by two methods: HR-pQCT and ultrasound. 84 patients will be measured. The cohort will be: * 21 women less than 70 * 21 women...
Eligibility Criteria
Inclusion
- being 18 or older
- coming from the rheumatology consultation at Lariboisière Hospital
Exclusion
- BMI \> 28
- BMI \< 15
- cortisone treatment
- recent fracture at non-dominant arm
- wound on measuring zone
- treatment interfering with bone architecture or bone density : oral of transdermic oestrogenes, bisphosphonates (Alendronate, Risedronate, Zoledronate) or Denosumab during the past 6 months-
Key Trial Info
Start Date :
March 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 19 2019
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03453242
Start Date
March 2 2018
End Date
July 19 2019
Last Update
September 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cohen-Solal
Paris, Île-de-France Region, France, 75010